Tag: DoE

Managing Out-of-Specification Results in Pilot Scale Manufacturing Unexpected Out-of-Specification (OOS) results during pilot scale manufacturing can create significant challenges in maintaining quality and timeline adherence in pharmaceutical development. Understanding how…

Managing Unexpected OOS Results in Pilot Scale Manufacturing Unexpected Out-of-Specification (OOS) results during pilot scale manufacturing can pose significant challenges for pharmaceutical professionals. Such occurrences can delay developments and cause…

Formulation Adjustments from Lab to Pilot Scale: Recognizing Challenges and Solutions In pharmaceutical manufacturing, transitioning from lab-scale formulation to pilot scale marks a crucial phase that can unveil a variety…

Pilot Scale Formulation Adjustments: Navigating Changes in the Scale-Up Process In pharmaceutical manufacturing, transitioning from lab scale to pilot scale can present significant challenges. These challenges may manifest during the…

Addressing Lab-to-Pilot Scale Challenges: Developing a Comprehensive Risk Register The transition from lab-scale formulations to pilot-scale production presents numerous challenges that can significantly impact project timelines and resource allocation. When…

Establishing an Effective Risk Management Framework for Lab to Pilot Scale Challenges Transitioning from lab scale to pilot scale presents unique challenges in pharmaceutical manufacturing. Insufficient risk management can lead…

Strengthening Deviation Capture in Pilot Scale Batches In the pharmaceutical industry, the transition from lab-scale to pilot-scale production presents a myriad of challenges, particularly in the realm of deviation management.…

Enhancing Deviation Capture in Pilot Scale Batches: A Case Study In the regulatory landscape of pharmaceutical manufacturing, the transition from lab-scale to pilot-scale production can unveil numerous challenges that require…

Overcoming Lab to Pilot Scale Challenges in Pharmaceutical Manufacturing The process of transitioning pharmaceutical formulations from laboratory scale to pilot scale can present various challenges that may jeopardize the overall…

Pilot Scale Process Characterization and Its Challenges During Commercial Transfer The transition from lab-scale to pilot-scale in pharmaceutical manufacturing often exposes several challenges that can compromise process integrity and quality.…

Translating Lab Stirring Speed for Pilot Scale Mixing: A Practical Guide In the pharmaceutical industry, transitioning from lab-scale experiments to pilot-scale operations presents a set of unique challenges, particularly when…

Translating Stirring Speed from Lab to Pilot Scale: A Practical Approach In pharmaceutical manufacturing, transitioning from lab-scale to pilot-scale operations is fraught with challenges, particularly concerning mixing parameters. Misalignments in…